Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion type Assertion NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_head.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion description "[FLT3-activating internal tandem duplication (ITD) mutations are found in approximately 30% of patients with AML and are associated with poor outcome in this patient population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_provenance.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion evidence source_evidence_literature NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_provenance.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion SIO_000772 23412931 NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_provenance.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion wasDerivedFrom befree-2016 NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_provenance.
- NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_assertion wasGeneratedBy ECO_0000203 NP1053278.RAf4lXMXdbvE3nbIk7aJFm-yp9bMd4YIMfVrJNma7xYxg130_provenance.